Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients

Senturk S., Hatirnaz S., Kanat-Pektas M.

MEDICAL SCIENCE MONITOR, vol.24, pp.7517-7523, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24
  • Publication Date: 2018
  • Doi Number: 10.12659/msm.912957
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.7517-7523
  • Keywords: Body Mass Index, Islet Amyloid Polypeptide, Polycystic Ovary Syndrome, INSULIN-SECRETION, OBESITY, WOMEN, GROWTH
  • Recep Tayyip Erdoğan University Affiliated: Yes


Background: Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aimed to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups (<25 kg/m(2) and >= 25 kg/m(2)).